Key Takeaways
- Applikon Biotechnology, based in Delft, The Netherlands, is a groundbreaking startup focusing on the development and supply of advanced bioreactor systems.
- The company offers a unique, all-encompassing platform that supports customers from initial screening stages up to full-scale production.
- They have a strong focus on continuous technological innovation, resulting in state-of-the-art equipment and evolving solutions for the biotech and pharmaceutical industry.
- The unique ability to offer a complete solution on a mini and micro bioreactor scale sets Applikon apart from other suppliers.
- Applikon prioritizes long-term relationships with its global clientele, supporting them with all-round validation and documentation.
Introduction
Technology today is revolutionizing various industries, including biotechnology. Revolution comes in the form of startups like Applikon Biotechnology, located in Delft, The Netherlands. Applikon is a pioneering biotech company that develops and supplies advanced bioreactor systems from a laboratory scale to production scale. From initial screening to full-scale production, Applikon is the only company to take customers through each stage on the same platform, thus minimizing the risks typically associated with the scale-up process.
The company’s strength lies in its ability to innovate and bring new technologies to the market, providing process efficiency advances for research, development, pilot plant, and production scale processes. The slogan “A Step Ahead” encapsulates Applikon’s approach and ethos of offering state-of-the-art solutions while maintaining a clear focus on client needs in the biotech and pharmaceutical industry.
Analysis
What sets Applikon Biotechnology apart is its unique ability to provide a complete solution on a mini and micro bioreactor scale. No other company can offer this level of specificity and scale. The systems they create on a small scale generate results that can be upscaled to a production level. This strategic innovation and delivery have shown steady growth leading to Applikon’s rise to the top position of the worldwide laboratory bioreactor market.
The startup values are anchored in building strong relationships with leading international universities and institutes and its client pool that spans across the globe. Opting for long-term value creation over short-term shareholder gain, Applikon emphasises on long-lasting client relations and reliable solution delivery. It is noteworthy that validation and documentation are integral parts of Applikon Biotechnology’s development protocol.
Conclusion
The future of Applikon looks promising, as the firm continues to provide innovative solutions for the biotech and pharmaceutical industry. By maintaining its focus on advancing technology, providing unparalleled support from initial screening to full production, and fostering lasting relationships with its clients, Applikon is set to redefine bioreactor systems and revolutionise the biotechnology industry.
From R&D to cGMP production, thousands of Applikon bioreactors are in use around the world, demonstrating the substantial footprint the startup has already made. You can follow Applikon’s continued growth and success on their website or on their social media platforms, Twitter, Facebook, and LinkedIn.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
